Members of Blue Shield of California to receive administrative costs of the H1N1 virus vaccine

NewsGuard 100/100 Score

Blue Shield of California announced today that it will cover the administrative costs of the H1N1 virus (swine flu) vaccine for all its members, regardless of which plan they have. Blue Shield will be waiving prior authorizations, copays and deductibles for office visits when members go to an in-network doctor to get H1N1 vaccinations.

The U.S. Government will be providing H1N1 vaccinations (including the equipment, like syringes) free of charge. While providers will initially focus vaccination efforts on the most at-risk populations, members of all groups will be covered.

Blue Shield of California also provides prescription drug coverage for Tamiflu (oseltamivir) and Relenza (zanamivir) -- the two anti-viral drugs used to treat flu symptoms. The company has designated both drugs as Tier One prescriptions, which reduces the copayment that members make to get the medication. Coverage is also being extended for conditions authorized by the FDA under Emergency Use Authorization. This coverage applies to all members.

"We stand ready to help our members in every way possible," said Meredith Mathews, M.D., chief medical officer of Blue Shield of California. "We want to make it easy and affordable for everyone to get the care they need."

In addition, Blue Shield will be providing H1N1 educational materials to members in order to familiarize them with both prevention and treatment options.

  • http://www.mylifepath.com

  • Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Pre-vaccine COVID-19: US study reveals hospitalization rate of 5.7% and fatality rate of 1.7%